NTI 2.99% 6.9¢ neurotech international limited

Ann: Clinical Trial Publication Provisionally Accepted, page-43

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,213 Posts.
    lightbulb Created with Sketch. 96
    I don't know the ins and outs of FDA approval but surely you would need a bigger case study than 34 participants to be successful. While early results seem to be positive, maybe this will only open them up to more health care institutions jumping on board for larger trials.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
6.9¢
Change
0.002(2.99%)
Mkt cap ! $64.55M
Open High Low Value Volume
6.7¢ 7.2¢ 6.7¢ $45.29K 648.2K

Buyers (Bids)

No. Vol. Price($)
3 684701 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 100000 1
View Market Depth
Last trade - 15.37pm 22/11/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.